RxDoctor Payments Data

Stephen Boswank

Medical Oncology · Mesquite, TXNPI 1346287992

Payments from drug & device makers

$6,639in general payments, 2019–2025

Across 80 payments — averaging $82.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$5K
  • Novartis$380
  • E.r. Squibb & Sons, L.L.C.$303
  • Incyte Corporation$252
  • Merck$179
  • Johnson & Johnson$129
  • plus $585 from 17 others

What the payments were for

  • Food & beverage$1,22564%
  • Education$38720%
  • Other$29916%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,639 in reported general payments places this provider in the 35th percentile of 495 medical oncology providers in Texas.

See all medical oncology providers in Texas

Other medical oncology in Mesquite

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →